Trilaciclib - Latest Advances

A decade of progress in small-cell lung cancer (2015-2025): a narrative review.

Journal: European journal of clinical pharmacology

Published: April 21, 2026

Cyclotherapy: exploiting cell-cycle decoupling for selective cancer cytotoxicity and normal-tissue protection.

Journal: Cancer treatment reviews

Published: March 13, 2026

ToPCourT protocol: a phase II trial of Trilaciclib, Pembrolizumab, gemcitabine, and Carboplatin in locally advanced/unresectable or metastatic Triple-negative breast cancer.

Journal: Future oncology (London, England)

Published: March 11, 2026

In silico discovery of fructosamine-3-kinase inhibitors targeting the Nrf2-mediated antioxidant response in cancer cells: a molecular dynamics approach.

Journal: In silico pharmacology

Published: January 08, 2026

NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 26, 2025

Efficacy and safety of trilaciclib to prevent chemotherapy-induced myelosuppression in advanced solid tumors: a systematic review and meta-analysis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 01, 2025

The value and safety of trilaciclib in combination with first-line chemotherapy and immunotherapy for extensive-stage SCLC.

Journal: Immunotherapy

Published: September 11, 2025

CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis.

Journal: Nature genetics

Published: September 09, 2025

Case Report: Analysis of short-term clinical efficacy of trilaciclib in patients with advanced lung neuroendocrine carcinoma undergoing chemotherapy.

Journal: Frontiers in oncology

Published: August 14, 2025

CDK4/6 inhibition enhances CAR-T cell therapy in solid tumors.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 19, 2025

Comparing the Efficacy of Various Treatment Strategies for Patients With Advanced Triple-Negative Breast Cancer: An Umbrella Review.

Journal: Clinical pharmacology and therapeutics

Published: June 18, 2025

Application value and safety of trilaciclib in first-line chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer: A real-world study.

Journal: Oncology letters

Published: May 23, 2025